ANDA 85739, held by Watson Labs. Phentermine Hydrochloride.
As of Nov 16, 2026, ANDA 85739 (Phentermine Hydrochloride), held by Watson Labs, was first approved by FDA on May 19, 1978, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 19, 1978 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Phentermine Hydrochloride8MG ยท tablet;oral | Phentermine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters